Literature DB >> 23540544

Dramatically different phenotypic expressions of hypertrophic cardiomyopathy in male cousins undergoing cardiac transplantation with identical disease-causing gene mutation.

William C Roberts1, Carey Camille Roberts, Jong Mi Ko, Paul A Grayburn, Anumeha Tandon, Johannes J Kuiper, John E Capehart, Shelley A Hall.   

Abstract

Described herein are certain findings in 2 male cousins who underwent cardiac transplantation for severe heart failure (HF), one of the diastolic type (ejection fraction ≈65%), and one of the systolic type (ejection fraction ≈20%), both the consequence of hypertrophic cardiomyopathy (HC), and each had identical disease-causing gene mutations. The implanted heart in one had normal-sized ventricular cavities and no grossly visible ventricular wall lesions (except in one papillary muscle) and the other patient had severely dilated ventricular cavities and multiple extensive ventricular wall scars. The heart mass and the age of onset of symptoms was similar in each patient. A number of other family members had evidence of HC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23540544     DOI: 10.1016/j.amjcard.2013.02.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy.

Authors:  Massimiliano Cecconi; Maria I Parodi; Francesco Formisano; Paolo Spirito; Camillo Autore; Maria B Musumeci; Stefano Favale; Cinzia Forleo; Claudio Rapezzi; Elena Biagini; Sabrina Davì; Elisabetta Canepa; Loredana Pennese; Mauro Castagnetta; Dario Degiorgio; Domenico A Coviello
Journal:  Int J Mol Med       Date:  2016-09-07       Impact factor: 4.101

2.  Morphologic features of the recipient heart in patients having cardiac transplantation and analysis of the congruence or incongruence between the clinical and morphologic diagnoses.

Authors:  William C Roberts; Carey Camille Roberts; Jong Mi Ko; Giovanni Filardo; John Edward Capehart; Shelley Anne Hall
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

3.  Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy.

Authors:  Elena V Filatova; Natalia S Krylova; Ivan N Vlasov; Maria S Maslova; Natalia G Poteshkina; Petr A Slominsky; Maria I Shadrina
Journal:  Mol Genet Genomic Med       Date:  2021-10-01       Impact factor: 2.183

Review 4.  MicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So Far.

Authors:  Catarina Roma-Rodrigues; Luís R Raposo; Alexandra R Fernandes
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.